Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 445

    1.

    Antihypertensive medication prescribing in 27,822 elderly Canadians with diabetes over the past decade.

    McAlister FA, Campbell NR, Duong-Hua M, Chen Z, Tu K.

    Diabetes Care. 2006 Apr;29(4):836-41.PMID: 16567824 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.

    Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY.

    Pharmacoepidemiol Drug Saf. 2007 Apr;16(4):412-21.PMID: 17252613 [PubMed - indexed for MEDLINE]Related articles

    3.

    Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement.

    Campbell NR, McAlister FA, Duong-Hua M, Tu K.

    Can J Cardiol. 2007 Aug;23(10):783-7.PMID: 17703255 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002.

    Tu K, Campbell NR, Duong-Hua M, McAlister FA.

    Hypertension. 2005 Jun;45(6):1113-8. Epub 2005 Apr 25.PMID: 15851629 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program.

    Campbell NR, McAlister FA, Brant R, Levine M, Drouin D, Feldman R, Herman R, Zarnke K; Canadian Hypertension Education Process and Evaluation Committee.

    J Hypertens. 2003 Aug;21(8):1591-7.PMID: 12872055 [PubMed - indexed for MEDLINE]Related articles

    6.

    Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study.

    Psaty BM, Savage PJ, Tell GS, Polak JF, Hirsch CH, Gardin JM, McDonald RH Jr.

    JAMA. 1993 Oct 20;270(15):1837-41.PMID: 8105112 [PubMed - indexed for MEDLINE]Related articles

    7.

    The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends.

    Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force.

    Hypertension. 2006 Jan;47(1):22-8. Epub 2005 Dec 12.PMID: 16344380 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hypertension guidelines in elderly patients: is anybody listening?

    Tu K, Mamdani MM, Tu JV.

    Am J Med. 2002 Jul;113(1):52-8.PMID: 12116987 [PubMed - indexed for MEDLINE]Related articles

    9.

    Thiazide diuretics for hypertension: prescribing practices and predictors of use in 194,761 elderly patients with hypertension.

    Tu K, Campbell NR, Chen Z, McAlister FA.

    Am J Geriatr Pharmacother. 2006 Jun;4(2):161-7.PMID: 16860263 [PubMed - indexed for MEDLINE]Related articles

    10.

    How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.

    Guo JD, Liu GG, Christensen DB, Fu AZ.

    Value Health. 2003 Jan-Feb;6(1):18-28.PMID: 12535235 [PubMed - indexed for MEDLINE]Related articles

    11.

    Antihypertensive medication use by recently diagnosed hypertensive Canadians.

    Neutel CI, Campbell NR.

    Can J Cardiol. 2007 May 15;23(7):561-5.PMID: 17534463 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.

    Weiss R, Buckley K, Clifford T.

    Clin Ther. 2002 Sep;24(9):1451-62.PMID: 12380636 [PubMed - indexed for MEDLINE]Related articles

    13.

    Treatment of hypertension in patients with comorbidities: results from the study of hypertensive prescribing practices (SHyPP).

    Mehta SS, Wilcox CS, Schulman KA.

    Am J Hypertens. 1999 Apr;12(4 Pt 1):333-40.PMID: 10232492 [PubMed - indexed for MEDLINE]Related articles

    14.

    Antihypertensive drug prescription trends at the primary health care centres in Bahrain.

    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.

    Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27.PMID: 11501335 [PubMed - indexed for MEDLINE]Related articles

    15.

    Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?

    Gulliford MC, Charlton J, Latinovic R.

    J Hum Hypertens. 2005 Feb;19(2):111-7.PMID: 15361893 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment gaps for hypertension management in rural Canadian patients with type 2 diabetes mellitus.

    Supina AL, Guirguis LM, Majumdar SR, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA.

    Clin Ther. 2004 Apr;26(4):598-606.PMID: 15189757 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antihypertensive persistence and drug class.

    Marentette MA, Gerth WC, Billings DK, Zarnke KB.

    Can J Cardiol. 2002 Jun;18(6):649-56.PMID: 12107422 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.

    Stafford RS, Monti V, Furberg CD, Ma J.

    Hypertension. 2006 Aug;48(2):213-8. Epub 2006 Jun 19.PMID: 16785334 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.

    Al Khaja KA, Sequeira RP, Mathur VS.

    Ann Pharmacother. 2001 Nov;35(11):1350-9.PMID: 11724081 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.

    Al Khaja KA, Sequeira RP.

    Pharmacoepidemiol Drug Saf. 2006 Oct;15(10):741-8.PMID: 16342299 [PubMed - indexed for MEDLINE]Related articles